LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$89.04 USD
-0.82 (-0.91%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $89.05 +0.01 (0.01%) 7:38 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for LeMaitre Vascular, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 30.11 | 20.64 | 26.91 | 21.22 | 17.93 |
Depreciation/Amortization & Depletion | 9.52 | 9.43 | 11.07 | 8.40 | 5.42 |
Net Change from Assets/Liabilities | -11.25 | -13.40 | -9.96 | 0.86 | -13.89 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 8.39 | 8.71 | 7.09 | 4.32 | 4.72 |
Net Cash From Operating Activities | 36.75 | 25.38 | 35.10 | 34.80 | 14.18 |
Property & Equipment | -7.27 | -2.37 | -4.88 | -0.96 | -3.76 |
Acquisition/ Disposition of Subsidiaries | -0.90 | 0.00 | 0.00 | -72.63 | -21.24 |
Investments | -16.55 | -8.00 | -56.19 | 20.70 | 0.90 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -24.72 | -10.37 | -61.08 | -52.89 | -24.10 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.32 | 2.82 | 62.44 | 5.40 | 4.17 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -39.00 | 39.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -12.45 | -10.99 | -9.34 | -7.70 | -6.74 |
Other Financing Activities | 0.00 | -1.07 | -0.40 | -4.55 | -2.06 |
Net Cash from Financing Activities | -7.13 | -9.23 | 13.70 | 32.16 | -4.62 |
Effect of Exchange Rate Changes | 0.23 | -0.49 | -0.64 | 0.91 | 0.01 |
Net Change In Cash & Equivalents | 5.14 | 5.28 | -12.91 | 14.98 | -14.53 |
Cash at Beginning of Period | 19.13 | 13.86 | 26.76 | 11.79 | 26.32 |
Cash at End of Period | 24.27 | 19.13 | 13.86 | 26.76 | 11.79 |
Diluted Net EPS | 1.34 | 0.93 | 1.25 | 1.04 | 0.88 |
Fiscal Year End for LeMaitre Vascular, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 21.71 | 9.89 | 30.11 | 21.64 | 14.14 |
Depreciation/Amortization & Depletion | 4.77 | 2.38 | 9.52 | 7.07 | 4.68 |
Net Change from Assets/Liabilities | -17.39 | -9.86 | -11.25 | -8.57 | -8.58 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 5.60 | 2.67 | 8.39 | 5.86 | 3.94 |
Net Cash From Operating Activities | 14.70 | 5.07 | 36.75 | 26.01 | 14.18 |
Property & Equipment | -3.25 | -1.37 | -7.27 | -5.99 | -4.93 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -0.90 | -0.90 | -0.43 |
Investments | -10.12 | -0.99 | -16.55 | -15.57 | -7.24 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -13.36 | -2.36 | -24.72 | -22.45 | -12.60 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.35 | 3.63 | 5.32 | 4.89 | 4.89 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -7.18 | -3.59 | -12.45 | -9.33 | -6.22 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -2.83 | 0.04 | -7.13 | -4.45 | -1.32 |
Effect of Exchange Rate Changes | -0.50 | -0.42 | 0.23 | -0.19 | 0.10 |
Net Change In Cash & Equivalents | -2.00 | 2.33 | 5.14 | -1.08 | 0.35 |
Cash at Beginning of Period | 24.27 | 24.27 | 19.13 | 19.13 | 19.13 |
Cash at End of Period | 22.27 | 26.60 | 24.27 | 18.05 | 19.49 |
Diluted Net EPS | 0.52 | 0.44 | 0.38 | 0.33 | 0.36 |